| View |
DR-XY32013_PI_01.pdf
|
DR-XY32013
|
Ivabradine (as hydrochloride)
|
Coralan
|
5mg
|
Film-Coated Tablet
|
-
|
Les Laboratoires Servier Industrie
|
France
|
-
|
20 April 2021
|
26 May 2026
|
| View |
|
DR-XY32026
|
INDAPAMIDE
|
VAZAMIDE SR
|
1.5mg
|
Sustained-Release Tablet
|
ANTIHYPERTENSIVE
|
Torrent Pharmaceuticals Ltd.
|
India
|
Renewal
|
15 May 2024
|
28 July 2029
|
| View |
|
DR-XY32027
|
Piperacillin (As Sodium) + Tazobactam (As Sodium)
|
Vigocid
|
2g/ 250mg
|
Lyophilized Sterile Powder For Injection (Iv)
|
Antibacterial (Penicillin with Beta-Lactamase Inhibitor)
|
YSS Laboratories Co., Inc.
|
Philippines
|
Automatic Renewal
|
30 January 2023
|
27 July 2028
|
| View |
|
DR-XY32028
|
Chlorphenamine Maleate + Phenylpropanolamine Hydrochloride
|
Cynosal
|
0.25mg / 6.25 mg per mL
|
Syrup (Oral Drops)
|
Antihistamine (Substituted alkylamine)/Nasal Decongestant (Sympathomimetic)
|
Lejal Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
21 July 2023
|
27 July 2028
|
| View |
|
DR-XY32031
|
Trimetazidine Dihydrochloride
|
Angimax
|
20 mg
|
Tablet
|
Antianginal agent ( Fatty Acid Oxidation [pFOX] Inhibitor)
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
10 May 2023
|
27 July 2028
|
| View |
|
DR-XY32046
|
Piracetam
|
Lilonton
|
200mg/ mL (1000mg/ 5mL)
|
Solution for Injection (IM/IV)
|
NOOTROPIC
|
Siu Guan Chem. Ind. Co., Ltd.
|
China
|
Automatic Renewal
|
05 August 2021
|
31 July 2026
|
| View |
|
DR-XY32047
|
Famotidine
|
Voker
|
40 mg
|
Film-Coated Tablet
|
H2-Receptor Antagonist
|
Y.S.P. INDUSTRIES (M) SDN. BHD.
|
Malaysia
|
Renewal
|
20 June 2022
|
14 August 2027
|
| View |
|
DR-XY32049
|
Salbutamol Sulfate + Guaifenesin
|
Asbunyl Plus
|
1mg /50 mg per 5 mL
|
Syrup
|
Expectorant/ Beta-2-Adrenoreceptor Agonist
|
La Croesus Pharma, Inc.
|
Philippines
|
Automatic Renewal
|
09 June 2021
|
31 July 2026
|
| View |
|
DR-XY32062
|
Glimepiride
|
Acotril
|
4 mg
|
Tablet
|
Oral Hypoglycemic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
03 June 2021
|
01 August 2026
|
| View |
|
DR-XY32073
|
Getryl
|
Glimepiride
|
2mg
|
Tablet
|
-
|
Getz Pharma (Pvt.) Ltd.
|
Pakistan
|
-
|
19 May 2021
|
01 August 2026
|
| View |
|
DR-XY32079
|
Getryl
|
Glimepiride
|
3mg
|
Tablet
|
-
|
Getz Pharma (Pvt.) Ltd.
|
Pakistan
|
-
|
17 May 2021
|
04 August 2026
|
| View |
|
DR-XY32085
|
Levofloxacin (As Hemihydrate)
|
Levox
|
750 mg
|
Film Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
19 April 2022
|
06 June 2027
|
| View |
|
DR-XY32119
|
Amino acids
|
Celemin Nephro
|
70mg/mL (7% w/v)
|
Intavenous injection
|
PARENTERAL NUTRITION
|
Claris Otsuka Private Limited
|
India
|
Automatic Renewal
|
04 June 2021
|
11 August 2026
|
| View |
|
DR-XY32122
|
Cefixime (as Trihydrate)
|
SITIFIX
|
100mg/ 5mL
|
Granules for Suspension
|
-
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
-
|
31 March 2023
|
14 August 2026
|
| View |
|
DR-XY32133
|
Paracetamol + Thiamine Mononitrate (Vitamin B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
Dolo-Neurobion
|
500 mg/50 mg/100 mg/100 mcg
|
Film-Coated Tablet
|
Analgesic/Antipyretic/Vitamins
|
PT Merck Tbk
|
Indonesia
|
Automatic Renewal [OTC]
|
28 April 2021
|
14 August 2026
|
| View |
|
DR-XY32142
|
Guaifenesin + Salbutamol (as Sulfate)
|
Erventril Forte
|
50mg/ 1mg per 5mL
|
Syrup
|
Expectorant / Anti-Asthma
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
05 August 2021
|
15 August 2026
|
| View |
|
DR-XY32152
|
Leuprorelin Acetate
|
Endrolin
|
3.75mg/ Vial
|
Solution for Injection (I.M./S.C.)
|
Gonadotropin Releasing Hormone Analogue
|
Eriochem S.A.
|
Argentina
|
Automatic Renewal
|
19 August 2021
|
16 August 2026
|
| View |
|
DR-XY32156
|
Cytarabine
|
None
|
100 mg/mL
|
Solution for Injection (I.V./S.C.)
|
-
|
Zydus Hospira Oncology Pvt. Ltd.
|
India
|
Initial (Variation)
|
27 July 2022
|
27 July 2027
|
| View |
|
DR-XY32157
|
Glimepiride
|
Glipride
|
2 mg
|
Tablet
|
Oral Hypoglycemic (Sulfonylurea)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
17 June 2022
|
16 August 2026
|
| View |
|
DR-XY32170
|
Cefixime ( As Trihydrate)
|
Synmex
|
200 mg
|
Capsule
|
Antibacterial (Cephalosporins)
|
Synmedic Labboratories
|
India
|
Automatic Renewal
|
13 September 2021
|
22 August 2026
|